Latest filing published 04 Jun 2026 for Lexicon Pharmaceuticals, INC..
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Raymond Debbane, listed as board member, has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Lexicon Pharmaceuticals, Inc., WW International, Inc. and Blue Buffalo Pet Products, Inc. The record holds 111 filings, for trades running from 4 January 2016 to 3 June 2026.
On the market, this insider has only ever bought: 64 purchases, €6.0M in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 37 share grants and 7 option exercises. 2026 to date brings 7 purchases and no sales.
The median purchase comes to €9,638. On 60 out of 64 purchases, another insider of the same company was buying within the same 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.
The record was last updated on 4 June 2026 with an option exercise in Lexicon Pharmaceuticals, Inc. The last insider purchase was made public on 27 February 2026, 239 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
22 of 22 declarations